Tuberculosis preventative treatment also prevented diarrhoea in HIV-infected patients in Zambia [9]

AIDS

Volumn 16, Issue 5, 2002, Pages 806-808

  Mwinga, Alwyn ^a,b   Hosp, Maria ^b   Zulu, Isaac ^a,c   Farthing, Michael J G ^d   Mulambo, Sylvia ^b   Kelly, Paul ^a,c  

^a UNIVERSITY OF ZAMBIA   (Zambia)

^b UNIVERSITY OF ZAMBIA   (Zambia)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN; RIFAMYCIN;

COMORBIDITY; DIARRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUBERCULOSIS; ZAMBIA;

EID: 0037192591     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200203290-00026     Document Type: Letter

References (5)

1. Impact of HIV on tuberculosis in Zambia: A cross-sectional study
2. Micronutrient supplementation in IDS diarrhoea-wasting syndrome in Zambia: A randomised controlled trial
3. Twice weekly preventive therapy in HIV infection in Zambia
4. Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection
5. Contrasting incidence of Clostridium difficile in AIDS patients in London and Lusaka